Drug diversion rarely begins with a dramatic event. More often, it develops quietly through small workflow gaps, unresolved discrepancies, documentation inconsistencies, or behavioral patterns that go unnoticed over time.
That is why the strongest healthcare organizations do not rely solely on incident response. Instead, they build structured drug diversion mitigation programs that combine pharmacy leadership, interdisciplinary collaboration, continuous monitoring, and a culture of accountability.
Start with a clear diversion risk picture.
If your organization hasn’t conducted a recent diversion risk review, now is the time.
→ Request a Free 30-Minute Drug Diversion Risk Assessment
In a recent episode of the Diversion Insights Podcast, pharmacy leaders from a hospital in the Washington, DC metro area shared how their organization gradually built a comprehensive diversion mitigation framework. Their experience illustrates how hospitals can strengthen controlled substance oversight through leadership vision, operational discipline, and proactive collaboration across departments.
You can also listen to the Diversion Insights Podcast on Spotify, where healthcare leaders discuss real-world strategies for drug diversion mitigation, compliance, and controlled substance oversight.
This article highlights the key insights from that conversation and explores how hospitals can apply similar strategies to strengthen their own drug diversion mitigation programs.
Drug Diversion Is a Patient Safety and Compliance Risk
Controlled substances are essential to patient care, but they also present unique risks when monitoring systems fail or oversight is inconsistent.
Drug diversion in healthcare settings can expose patients to contaminated medications, untreated pain, or impaired care from healthcare workers struggling with substance use. The Joint Commission recognizes diversion as a significant patient safety concern and encourages hospitals to implement robust detection and response systems.
The American Society of Health-System Pharmacists (ASHP) also recommends that hospitals implement structured diversion mitigation programs that include monitoring systems, reporting mechanisms, and interdisciplinary oversight.
Hospitals that build these systems proactively are better equipped to detect risks early and protect both patients and staff.
Leadership Vision Drives Strong Diversion Mitigation Programs
One of the most important insights from the podcast is that this hospital’s diversion mitigation program did not develop overnight.
Nearly fifteen years ago, pharmacy leadership recognized an opportunity to redesign how medication safety responsibilities were managed within the organization. Instead of replacing a retiring part-time medication safety officer with a similar role, leadership expanded the position and moved oversight under pharmacy leadership.
Over time, this effort evolved into a dedicated pharmacy quality, safety, and regulatory division.
Today, that division includes:
- Two pharmacists focused on safety and compliance
- Two pharmacy technicians supporting auditing and monitoring
- Structured regulatory oversight
- Cross-department collaboration with nursing, medical staff, and hospital leadership
The program grew gradually as leadership demonstrated the value of stronger monitoring systems and improved regulatory compliance.
This incremental approach allowed the hospital to strengthen its diversion mitigation capabilities while building organizational support.
Every healthcare organization needs a clear diversion mitigation strategy.
Independent evaluations can identify monitoring gaps before they become compliance issues.
→ Speak With Terri Vidals, Diversion Mitigation Specialist
Pharmacy Technicians Strengthen Monitoring Systems
Another key factor in this hospital’s success is its strategic use of experienced pharmacy technicians.
Rather than assigning all diversion mitigation responsibilities to pharmacists, leadership evaluated which tasks could be effectively handled by trained technicians. These responsibilities now include auditing medication workflows, reviewing discrepancy reports, and monitoring controlled substance documentation.
This structure significantly increases monitoring capacity while allowing pharmacists to focus on clinical and leadership responsibilities.
ASHP guidelines encourage healthcare organizations to clearly define staff roles within diversion mitigation programs and to utilize pharmacy technicians appropriately.
When organizations use the full capabilities of their pharmacy teams, monitoring programs become far more effective.
Daily Auditing Strengthens Controlled Substance Oversight
One of the strongest elements of this hospital’s program is its consistent auditing process.
The pharmacy quality and regulatory team performs daily, weekly, and monthly audits of controlled substance workflows.
Daily monitoring includes:
- Reviewing resolved Pyxis discrepancies
- Verifying override activity against provider orders
- Reconciling C-II vault transactions each shift
- Monitoring medication removals after patient discharge
- Reviewing anesthesia medication transactions
Weekly audits include nursing unit inventory compliance reviews and additional documentation checks.
This layered approach aligns with national recommendations that hospitals use multiple monitoring systems to detect diversion risks.
Diversion often hides in complex medication data.
Advanced analytics can identify patterns that manual audits miss.
→ Request a Free 30-Minute Drug Diversion Risk Assessment
Strengthening Oversight in High-Risk Clinical Areas
Certain clinical environments present higher diversion risks due to the speed and complexity of medication workflows.
Anesthesia and perioperative settings are particularly vulnerable because controlled substances are frequently dispensed and administered rapidly during procedures.
To mitigate this risk, the hospital implemented a daily reconciliation process for anesthesia medications.
A pharmacist reviews every transaction to ensure that medication dispensing, administration, and waste documentation match appropriately.
If discrepancies appear, the pharmacy team contacts the clinician involved and escalates unresolved issues within 48 hours.
The organization also implemented a safeguard preventing anesthesia cases from being closed until discrepancies are resolved.
The Centers for Disease Control and Prevention (CDC) has documented healthcare diversion incidents where tampered medications exposed patients to infectious diseases.
These cases highlight why strong monitoring systems are essential for patient protection.
Trend Monitoring Helps Identify Diversion Early
Another important lesson from the podcast is the importance of trend analysis.
Diversion does not always appear as large missing quantities. Instead, it may emerge through small patterns such as:
- recurring discrepancy corrections
- unusual override patterns
- medication pulls without documentation
- repeated charting inconsistencies
When evaluated individually, these events may seem minor. However, analyzing trends over time can reveal deeper risks.
This approach allows healthcare teams to identify potential diversion earlier and intervene appropriately.
Technology Supports Diversion Mitigation — But People Matter
Diversion detection software has become a valuable tool for healthcare organizations. These systems analyze medication data to identify unusual patterns.
However, the hospital leaders emphasized that technology alone cannot detect every risk.
Their mitigation strategy combines:
- centralized diversion monitoring software
- pharmacy-generated audit reports
- manual discrepancy review
- peer-reported behavioral concerns
In fact, one confirmed diversion concern surfaced through peer observation rather than software alerts.
This reinforces the importance of strong reporting culture within healthcare organizations.
Controlled substance oversight requires coordination between pharmacy, nursing, and compliance teams.
Independent monitoring can strengthen that process.
→ Explore Rxpert Solutions Diversion Monitoring Services
Culture and Reporting Are Critical
Healthcare professionals may hesitate to report suspicious behavior involving colleagues.
However, hospitals with transparent reporting cultures are more likely to detect diversion risks early.
Support resources are also important for healthcare professionals struggling with substance use disorder.
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides national treatment resources for individuals seeking recovery.
Healthcare organizations that combine accountability with recovery support often see better outcomes for both patients and staff.
Continuous Improvement Strengthens Mitigation Programs
The hospital continues strengthening its diversion mitigation program through several ongoing initiatives.
These include:
- evaluating security camera coverage in medication areas
- improving documentation procedures
- assigning diversion mitigation champions in high-risk departments
- expanding interdisciplinary diversion oversight committees
- increasing staff education on diversion indicators
Diversion mitigation programs must evolve continuously as healthcare workflows and regulatory expectations change.
What Healthcare Leaders Can Learn
Healthcare leaders responsible for controlled substance oversight can learn several important lessons from this case.
Strong diversion mitigation programs typically include:
• clear leadership accountability
• interdisciplinary collaboration
• consistent auditing of medication workflows
• trend-based monitoring strategies
• technology combined with human oversight
• staff education and reporting culture
Organizations that implement these elements are better positioned to detect risks early and maintain regulatory compliance.
